Postoperative direct‐acting antiviral treatment after liver resection in patients with hepatitis C virus‐related hepatocellular carcinoma
Postoperative direct‐acting antiviral treatment after liver resection in patients with hepatitis C virus‐related hepatocellular carcinoma
Shogo Tanaka,H. Shinkawa,10 Authors,S. Kubo
2021 · DOI: 10.1111/hepr.13709
Hepatology Research · 13 Citations
TLDR
Effects of direct‐acting antiviral (DAA)–induced sustained virological response (SVR) after liver resection in patients with hepatitis C virus–related hepatocellular carcinoma for postoperative recurrence and survival are investigated.
Abstract
We investigated effects of direct‐acting antiviral (DAA)–induced sustained virological response (SVR) after liver resection in patients with hepatitis C virus (HCV)–related hepatocellular carcinoma (HCC) for postoperative recurrence and survival.